Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1988-6-7
|
pubmed:abstractText |
Serum ferritin level was measured serially in three malignant histiocytosis (MH) and five virus-associated hemophagocytic syndrome (VAHS) patients. Serum ferritin levels were greater than 1000 ng/ml at the early phase of disease. When disseminated intravascular coagulation (DIC) developed in patients, serum ferritin levels elevated further to greater than 12,000 ng/ml. MH patients were treated by combination chemotherapy, and VAHS patients were given prednisone. Each MH and VAHS patient died within 1 week from the onset of DIC, without decrease of serum ferritin level. One MH patient with continued high serum ferritin levels for 3 months after DIC also died. The remaining patients with decreased serum ferritin values less than 1000 ng/ml at 3 months after DIC are now alive with normal serum ferritin levels. These results suggest that serum ferritin level in histiocytic proliferative disorders is a useful indicator of disease activity in both neoplastic and reactive conditions rather than only a marker of malignant process.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide,
http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine,
http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Ferritins,
http://linkedlifedata.com/resource/pubmed/chemical/Prednisone,
http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2071-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3359404-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:3359404-Combined Modality Therapy,
pubmed-meshheading:3359404-Cyclophosphamide,
pubmed-meshheading:3359404-Cytarabine,
pubmed-meshheading:3359404-Disseminated Intravascular Coagulation,
pubmed-meshheading:3359404-Doxorubicin,
pubmed-meshheading:3359404-Etoposide,
pubmed-meshheading:3359404-Ferritins,
pubmed-meshheading:3359404-Histiocytic Sarcoma,
pubmed-meshheading:3359404-Humans,
pubmed-meshheading:3359404-Plasma Exchange,
pubmed-meshheading:3359404-Prednisone,
pubmed-meshheading:3359404-Renal Dialysis,
pubmed-meshheading:3359404-Vincristine
|
pubmed:year |
1988
|
pubmed:articleTitle |
High serum ferritin level as a marker of malignant histiocytosis and virus-associated hemophagocytic syndrome.
|
pubmed:affiliation |
Department of Pediatrics, Kyoto Prefectural University of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|